Navigation Links
Public Health Experts Provide Update on Current Infectious Diseases Threats
Date:7/9/2008

WASHINGTON, July 9 /PRNewswire-USNewswire/ -- Updates on the impact of climate changes on insect-borne diseases, the control of MRSA infections, and the importance of childhood immunizations were presented today at a news conference at the National Press Club in Washington, D.C. The news conference, sponsored by the National Foundation for Infectious Diseases (NFID), also addressed the growing challenge of prevention and treatment of infections due to drug resistant bacteria.

"Infectious diseases pose an ongoing threat to the nation's public health," said Susan J. Rehm, MD, NFID medical director and vice chair, Department of Infectious Disease, at the Cleveland Clinic. "As health care professionals, we need to continue to identify these threats and educate the public about both prevention and effective measures to help control these threats."

The challenges associated with insect-borne infections and climate changes were presented by David M. Morens, M.D., at the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH). Approximately 1.5 million of 14.8 million annual infectious disease deaths are attributable to insect-borne diseases worldwide. These diseases, such as yellow fever, dengue fever, encephalitis, Chagas disease and leishmaniasis may cause conditions ranging from encephalitis to congestive heart failure, cirrhosis of the liver, blindness and hemorrhagic fevers. Scientists are studying the effects of global warming and the impact of climate changes on increasing insect-borne infections. "The most important needs are better understanding of the behavior of complex ecosystems to which insects belong, reinvigoration of scientific and public health defenses, and more powerful tools to prevent, control and treat insect-borne diseases," said Dr. Morens.

Additional topics discussed at the 13th Richard J. Duma/NFID Annual News Conference and Symposium on Infectious Diseases included:

-- How Should We Respond to MRSA?: Loren Miller, MD, MPH, director of the

Infection Control Program at Harbor-UCLA, associate professor of

medicine at the David Geffen School of Medicine at the University of

California, Los Angeles and faculty member in the division of Adult

Infectious Diseases at Harbor-UCLA Medical Center, discussed methods to

control and prevent MRSA infections. Methicillin-resistant

Staphylococcus aureus (MRSA) infections have become increasingly common

in the past few years. MRSA poses risk for infection within and outside

healthcare settings. MRSA are a type of Staphylococcus aureus

bacteria, commonly known as "Staph" that are resistant to many commonly

used antibiotics. "There is no simple magic bullet to respond to MRSA.

Efforts to prevent MRSA need to be multi-faceted and coordinated,"

stated Dr. Miller.

-- Childhood and Adolescent Vaccines: More Important than Ever: Larry K.

Pickering, MD, FAAP, senior advisor to the director of the National

Center for Immunization and Respiratory Diseases of the Centers for

Disease Control and Prevention, executive secretary of the Advisory

Committee on Immunization Practices (ACIP) and professor of pediatrics

in the department of pediatrics at Emory University School of Medicine

outlined the successes achieved by the immunization program; the

importance and benefits of childhood, adolescent and adult immunization

platforms; the effects of an unvaccinated population; and future

advances to further improved health. "Today, recommended vaccines are

available to prevent 16 infectious diseases as well as two forms of

cancer. As future vaccines become available to prevent other infectious

diseases, cancers, and other conditions, funding mechanisms must be

protected and public confidence in the safety and effectiveness of

vaccines must not be permitted to erode," stated Dr. Pickering.

-- Prevention and Treatment of Infections Due to Drug Resistant Bacteria:

Antibiotics Can't Be the Only Answer: Robert A. Weinstein, MD,

professor of medicine and chairman of the Division of Infectious

Diseases, Stroger Hospital at Cook County and chief operating officer

at the Ruth M. Rothstein CORE Center for the Prevention, Care and

Research of Infectious Diseases, Rush Medical College, Chicago,

Illinois provided an overview of antibiotic resistance and infection

control practices to help reduce its occurrence. "Antibiotic

resistance is driven by lapses in infection control, as well as by

antibiotic overuse. Infection control improvements are essential to

controlling antibiotic resistance," said Dr. Weinstein.

About the News Conference and Symposium

The 13th Richard J. Duma/NFID Annual News Conference and Symposium on Infectious Diseases was supported, in part, by unrestricted educational grants to NFID from Cubist Pharmaceuticals, Inc., Pfizer Inc., Ortho-McNeil Pharmaceutical, Roche, sanofi pasteur, and Wyeth Pharmaceuticals.

This event is named for former NFID president and executive director Richard J. Duma, MD, PhD, currently director of infectious diseases at Halifax Medical Center in Daytona Beach, Florida.

About the National Foundation for Infectious Diseases

The National Foundation for Infectious Diseases (NFID) is a non-profit, tax-exempt 501(c)(3) organization founded in 1973 and dedicated to educating the public and healthcare professionals about the causes, treatment and prevention of infectious diseases. For more information, please visit http://www.nfid.org.


'/>"/>
SOURCE National Foundation for Infectious Diseases
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mailman School of Public Health study examines link between racial discrimination and substance use
2. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
3. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
4. Open access to health research publications
5. MultiVu Video Feed: PUBLIC HEALTH EXPERTS CONVENE TO DISCUSS THE TREATMENT AND PREVENTION OF RABIES
6. PA Secretary of Public Welfare Responds to Warren State Hospital Closure Rumors
7. Weiner Public News First Media Team at National Press Club 5K
8. ComPsych(R) Corp. Announces Health at Work(SM) Award Winners: Sprint, Erie Insurance, City of Naperville and Green Hills Public Library
9. Exelixis Commences Public Offering of Common Stock
10. PA Department of Public Welfare Begins Outreach to Medical Assistance Consumers Following Burglary at State Office Building
11. Public Health and Need for Consistent Standards Preclude Exception for Breastfeeding Mother in National Medical Licensing Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , ... February 08, 2016 , ... Discover the Rocky ... over 1,400 booths and 700 companies. Attendees also get to see the most ... Colorado Garden & Home Show , at the Colorado Convention Center - 700 14th ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua Rosenthal, ... how healthcare companies can use newly released government data on populations and physicians ... and intervene and capture the value they create to succeed in new economic ...
(Date:2/7/2016)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... the ability to correct pelvic organ prolapse with the latest techniques and the ... at greatest risk for pelvic organ prolapse, particularly after menopause. Other risk factors ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , ... with an estimated 5000 perioperative nurses in attendance to study the latest ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... eating disorder treatment helps to reduce the frequency and level of relapse. ... Phase: Re-Establishing Healthy Identity and Purpose,” will explore the critical tasks of the ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... CITY, Calif., Feb. 8, 2016  Aoxing Pharmaceutical Company, Inc. (NYSE ... fiscal year 2016, ended December 31, 2015, the Company achieved ... recorded in the same quarter in fiscal 2015. ... in Q2 of fiscal year 2016 was $2,068,635, or $.03 ... or $.01 per share, in the Q2 of fiscal year ...
(Date:2/8/2016)... Feb. 8, 2016 ... of the "Label-Free Detection Market by ... 2020" report to their offering. ... addition of the "Label-Free Detection Market ... to 2020" report to their offering. ...
(Date:2/8/2016)...  HemaFlo Therapeutics, Inc. announced today that the United States ... 9,119,880 covering the use of NephroFlow to treat acute kidney ... founder, said, "We are pleased to secure our rights to ... , PhD, HemaFlo,s founder, said, "We are pleased to secure ... Dale Peterson , PhD, HemaFlo,s founder, said, "We ...
Breaking Medicine Technology: